---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-039764"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2024-09-09T23:59:59+00:00"
generated_at: "2026-05-31T05:54:00.215232+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Avalo posts updated investor presentation; no material new information disclosed

## Summary
- Filed 8-K on Sept 9, 2024 to announce availability of an updated investor presentation.
- Presentation posted on company website; no specific financial or operational updates provided in filing or exhibit.
- Ticker AVTX; presentation dated September 2024 but content beyond title slide not included in filing text.
- Investor presentation will be used in meetings with investors; no guidance or material events announced.

## SEC filing metadata
- accession: 0001628280-24-039764
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2024-09-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828024039764/0001628280-24-039764-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828024039764/avtx-20240909.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-039764
- JSON: https://secwatch.observer/filing/0001628280-24-039764.json
- Plain text: https://secwatch.observer/filing/0001628280-24-039764.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.